IGF1 and Crohn disease: Furthermore, with links to decreased IGF-1 levels in Crohn’s disease patients42, in parallel with the reductions in villin, this suggests a new mechanism by which h(GLY2)GLP-2 may attenuate Crohn’s disease43 and/or other inflammatory enteropathologies.